(2022) 8:eabq5384
The safety profile was consistent with GLP-1 receptor agonists, primarily featuring transient, mild-to-moderate gastrointestinal adverse events (e.g., nausea, 55%), with low discontinuation rates (6-8.4%)
They want a source they can review with confidence, backed by clear records and dependable product standards
How BPC-157 (Oral) Works Oral BPC-157 acts primarily through local gastrointestinal mechanisms and, to a debated extent, through systemic absorption from the gut
However, the evidence supporting this hypothesis is scarce, leading to controversy on the validity and especially the interpretation of the lactulose-mannitol test (21)
But what I'm saying is that just the concept of getting all these things out of our food supply, making people healthy, getting people off of all these prescription drugs, making people more metabolically healthy, we're so stupid with our tribal shit that just